Hughes VL. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina.
Obstet Gynecol. 1990;75:244 - 248.
Nobaek S, Johansson M-L, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Am J Gastroenterol. 2000;95:1231 - 1238.
Halpern GM, Prindiville T, Blankenberg M, et al. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.
Am J Gastroenterol. 1996;91:1579 - 1585.
Scarpignato C, Rampal P. Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Chemotherapy. 1995;41(suppl 1):48 - 81.
Shornikova AV, Casas IA, Mykkanen H, et al. Bacteriotherapy with
Lactobacillus reuteri
in rotavirus gastroenteritis.
Pediatr Infect DisJ. 1997;16:1103 - 1107.
Shornikova AV, Casas IA, Isolauri E, et al.
Lactobacillus reuteri
as a therapeutic agent in acute diarrhea in young children.
J Pediatr Gastroenterol Nutr. 1997;24:399 - 404.
Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of traveller's diarrhoea by
Lactobacillus GG.Ann Med.
1990;22:53 - 56.
Saavedra JM, Bauman NA, Oung I, et al. Feeding of
Bifidobacterium bifidum
and
Streptococcus thermophilus
to infants in hospital for prevention of diarrhoea and shedding of rotavirus.
Lancet.
1994;344:1046 - 1049.
Pedone CA, Bernabeu AO, Postaire ER, et al. The effect of supplementation with milk fermented by
Lactobacillus casei
(strain DN-114 001) on acute diarrhoea in children attending day care centres.
Int J Clin Pract.
1999;53:179 - 184.
Colombel JF, Cortot A, Neut C, et al. Yoghurt with
Bifidobacterium longum
reduces erythromycin-induced gastrointestinal effects.
Lancet.
1987;2:43.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA. 1996;275:870 - 876.
Hilton E, Kolakowski P, Singer C, et al. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers.
J Travel Med.
1997;4:41 - 43.
Kirchhelle VA, Fruhwein N, Toburen D. Treatment of persistent diarrhea with
Saccharomyces boulardii.
Results of a prospective study [en alemán, resumen en inglés].
Fortschr Med.
1996;114:136 - 140.
Kollaritsch VH, Holst H, Grobara P, et al. Prevention of traveler's diarrhea with
Saccharomyces boulardii.
Results of a placebo-controlled double-blind study [traducido del alemán].
Fortschr Med.
1993;111:152 - 156.
Chapoy P. Treatment of acute infantile diarrhea: controlled trial of
Saccharomyces boulardii
[en francés, resumen en inglés].
Ann Pediatr (Paris).
1985;32:561 - 563.
Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by
Saccharomyces boulardii:
a prospective study.
Gastroenterology
1989;96:981 - 988.
Surawicz CM, McFarland LV, Elmer G, et al. Treatment of recurrent Clostridium difficile colitis with vancomycin and
Saccharomyces boulardii.Am J Gastroenterol.
1989;84:1285 - 1287.
McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of Beta-lactam-associated diarrhea by
Saccharomyces boulardii
compared with placebo.
Am J Gastroenterol.
1995;90:439 - 448.
Bleichner G, Blehaut H, Mentec H, et al.
Saccharomyces boulardii
prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial.
Intensive Care Med.
1997;23:517 - 523.
Plein K, Hotz J. Therapeutic effects of
Saccharomyces boulardii
on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study.
Z Gastroenterol.
1993;31:129 - 134.
Elmer GW, Moyer KA, Vega R, et al. Evaluation of
Saccharomyces boulardii
for patients with HIV-related diarrhoea and in healthy volunteers receiving antifungals.
Microecol Ther.
1995;25:23 - 31.
Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.
J Pediatr Gastroenterol Nutr. 2000;30:54 - 60.
Simakachorn N, Pichaipat V, Rithipornpaisarn P, et al. Clinical evaluation of the addition of lyophilized, heat-killed
Lactobacillus acidophilus LB
to oral rehydration therapy in the treatment of acute diarrhea in children.
J Pediatr Gastroenterol Nutr. 2000;30:68 - 72.
Armuzzi A, Cremonini F, Ojetti V, et al. Effect of
Lactobacilos GG
supplementation on antibiotic-associated gastrointestinal side effects during
Helicobacter pylori
eradication therapy: a pilot study.
Digestion. 2001;63:1 - 7.
Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of
Lactobacillus GG
on antibiotic-associated diarrhea: a randomized, placebo-controlled trial.
Mayo Clin Proc.
2001;76:883 - 889.
Buydens P, Debeuckelaere S. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial.
Scand J Gastroenterol.
1996;31:887 - 891.
Vanderhoof JA, Whitney DB, Antonson DL, et al.
Lactobacillus GG
in the prevention of antibiotic-associated diarrhea in children.
J Pediatr.
1999;135:564 - 568.
Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea.
DICP.
1990;24:382 - 384.
Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
Lancet.
2001;357:1076 - 1079.
Isolauri E, Arvola T, Sutas Y, et al. Probiotics in the management of atopic eczema.
Clin Exp Allergy.
2000;30:1604 - 1610.
MacGregor G, Smith AJ, Thakker B, et al. Yoghurt biotherapy: contraindicated in immunosuppressed patients?
Postgrad Med J. 2002;78:366 - 367.
Reid G, Bruce AW, McGroarty JA, et al. Is there a role for
Lactobacilli
in prevention of urogenital and intestinal infections?
Clin Microbiol Rev.
1990;3:335 - 344.
McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract.
FEMS Immunol Med Microbiol.
1993;6:251 - 264.
Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis.
Ann Intern Med.
1992;116:353 - 357.
Friedlander A, Druker MM, Schachter A. Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection.
Panminerva Med. 1986;28:51 - 53.
Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vaginal supositories and vaginitis.
JClin Microbiol. 1995;33:1433.
Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic
Escherichia coli
versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
Lancet.
1999;354:635 - 639.
Faubion WA, Sandborn WJ. Probiotic therapy with
E. coli
for ulcerative colitis: take the good with the bad.
Gastroenterology.
2000;118:630 - 631.
Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial.
Gastroenterology.
2000;119:305 - 309.
Meydani SN, Ha WK. Immunological effects of yogurt.
Am J Clin Nutr.
2000;71:861 - 872.
Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of
Bifidobacterium lactis.
Eur J Clin Nutr.
2000;54:263 - 267.
Chiang BL, Sheih YH, Wang LH,et al. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses.
Eur J Clin Nutr. 2000;54:849 - 855.
Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.
BMJ.
2001;322:1 - 5.
Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing
Lactobacillus acidophilus
L1 on serum cholesterol in hypercholesterolemic humans.
J Am Coll Nutr.
1999;18:43 - 50.
Agerholm-Larsen L, Raben A, Haulrik N, et al. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases.
Eur J Clin Nutr.
2000;54:288 - 297.
Agerholm-Larsen L, Bell ML, Grunwald GK, et al. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies.
Eur J Clin Nutr. 2000;54:856 - 860.
Sakamoto I, Igarashi M, Kimura K, et al. Suppressive effect of
Lactobacillus gasseri
OLL 2716 (LG21) on
Helicobacter pylori
infection in humans.
J Antimicrob Chemother.
2001;47:709 - 710.
Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
FEMS Immunol Med Microbiol. 2003;35:131 - 134.
Pelto L, Isolauri E, Lilius EM, et al. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects.
Clin Exp Allergy.
1998;28:1474 - 1479.
Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and
Lactobacillus GG
drink for the prevention of urinary tract infections in women.
BMJ.
2001;322:1 - 5.
Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis.
J Allergy Clin Immunol. 2003;111:389 - 395.
Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability.
J Pediatr Gastroenterol Nutr. 2003;36:223 - 227.
Sen S, Mullan MM, Parker TJ, et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
Dig Dis Sci. 2002;47:2615 - 2620.
Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
Aliment Pharmacol Ther. 2003;17:895 - 904.
Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Am J Gastroenterol. 2002;97:2744-2749.
Rosenfeldt V, Michaelsen KF, Jakobsen M, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea.
Pediatr Infect Dis J. 2002;21:411-416.
Van Niel CW, Feudtner C, Garrison MM, et al. Lactobacillus Therapy for Acute Infectious Diarrhea in Children: A Meta-analysis.
Pediatrics. 2002;109:678-684.
Wendakoon CN, Thomson AB, Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection.
Digestion. 2002;65:16-20.
Isolauri E, Juntunen M, Rautanen T, et al. A human
Lactobacillus
strain (
Lactobacillus casei
sp strain GG) promotes recovery from acute diarrhea in children.
Pediatrics.
1991;88:90 - 97.
De Francesco V, Stoppino V, Sgarro C, et al. Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication.
Dig Liver Dis. 2000;32:746-747.
Szajewska H, Kotowska M, Mrukowicz JZ, et al. Efficacy of
Lactobacillus GG
in prevention of nosocomial diarrhea in infants.
J Pediatr.
2001;138:361 - 365.
Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of
Lactobacillus GG
to prevent diarrhea in undernourished Peruvian children.
J Pediatr.
1999;134:15 - 20.
Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates.
Aliment Pharmacol Ther. 2000;14:1625-1629.
Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.
Aliment Pharmacol Ther. 2001;15:163-169.
Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans
Digestion. 1999;60:203-209.
Felley CP, Corthesy-Theulaz I, Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.
Eur J Gastroenterol Hepatol. 2001;13:25-29.
Aiba Y, Suzuki N, Kabir AM, et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model.
Am J Gastroenterol. 1998;93:2097-2101.
O'Sullivan MA, et al. Bacterial supplementaion in the irritable bowel syndrome. A randomized double-blind placebo-controlled crossover study.
Digest Liver Dis. 2000;32:294-301.
Lievin V, Peiffer I, Hudault S, et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.
Gut. 2000;47:646 - 652.
Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2001;13:1143 - 1147.
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.
J Pediatr Gastroenterol Nutr. 2001;33(4 Suppl):S17 - S25.
Richelsen B, Kristensen K, Pedersen SB. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double blind study.
Eur J Clin Nutr. 1996;50:811 - 815.
Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia.
Eur J Clin Nutr. 1999;53:97 - 101.
Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men.
Eur J Clin Nutr. 1995;49:346 - 352.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic
Lactobacillus GG
reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study.
Pediatrics.
1999;104:e64.
Siitonen S, Vapaatalo H, Salminen S, et al. Effect of
Lactobacillus GG
yoghurt in prevention of antibiotic associated diarrhoea.
Ann Med.
1990;22:57 - 59.
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy.
J Allergy Clin Immunol. 1997;99:179 - 185.
Unger C, Haring B, Kruse A, et al. Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.
Arzneimittelforschung. 2001;51:332 - 338.
Urbancsek H, Kazar T, Mezes I, et al. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea.
Eur J Gastroenterol Hepatol. 2001;13:391 - 396.
Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
Gastroenterology. 2003;124:1202 - 1209.
Asli G, Alsheikh A, Weizman A. Effect of formula supplemented with two strains of probiotics on infections in day care infants. 2003 Pediatric Academic Societies' Annual Meeting, Seattle, Washington, May 3 - 6, 2003;abstract 998.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.